Latest On-Demand Webinars & Online Events

The human immune system is extremely complex, comprised of multiple cell types and states interacting in myriad ways to produce diverse cellular ecosystems.

Accessed via mobile, tablet or PC, this inaugural free-to-attend event will provide those working within academia and pharmaceutical development the opportunity to hear from experts within the field. Focus will be given to the latest advances in small molecule drug discovery and development, biopharma and biotechnology.

Full spectrum flow cytometry is becoming increasingly popular as it offers novel fluorescent dye combinations, improving flexibility and increasing multicolor panel size.

In this webinar, Dr. Richard Scott, Chief Medical Officer at Genomics England, will talk about the benefits and challenges of utilizing genetic technologies to understand disease at the individual level, and how this research is being applied to inform patient care.

Advancements in biotherapeutics have initiated an increasing range of complex molecules often presenting unique purification challenges. Addressing these challenges requires novel purification strategies for commercial manufacturing, which may not always exist. When your specific process needs cannot be met with off-the-shelve resins, custom resin production may be a viable solution.

Learn how scientists in the drug discovery field search for the most promising lead compounds. Dr. Claire Hatty from NanoTemper will highlight case studies demonstrating the value of biophysical tools in drug discovery workflows.

With safety concerns being the major cause for failures in Phase 1/2 clinical trials, it’s essential to develop more predictive models within preclinical drug discovery to improve data translatability.

Understanding the tissue-specific genetic architecture of protein levels is instrumental to understand the biology of health and disease.

Accessed via mobile, tablet or PC, this free-to-attend inaugural online symposium will provide cancer researchers with a unique opportunity to hear about the advances taking place within omics research, immunology, drug discovery and other notable topics.

Although the primary focus of the pharmaceutical industry has been identifying the mechanisms of drug elimination and potential drug liability, there is now an increasing focus on the kidney as a therapeutic target.